Method validation of in vitro RNA transcript analysis on the Agilent 2100 Bioanalyzer

Area of Science:

• Molecular Biology
• Biotechnology
• Analytical Chemistry

Background:

• Traditional methods for RNA analysis, such as gel electrophoresis and spectrophotometry, are time-consuming and may lack precision.
• The Agilent 2100 Bioanalyzer presents an automated alternative for comprehensive RNA characterization.

Purpose of the Study:

• To validate the Agilent 2100 Bioanalyzer for characterizing in vitro RNA transcripts.
• To assess the assay's performance according to International Conference on Harmonization guidelines.

Main Methods:

• Validation of the Agilent 2100 Bioanalyzer for RNA integrity, purity, concentration, and size analysis.
• Comparison of Bioanalyzer results with denatured agarose gel electrophoresis and UV spectrophotometry.
• Assessment of assay precision across different operators, days, and reagent lots.

Main Results:

• The assay demonstrates a linear quantitation range of 500 to 25 ng/µL.
• Quantitation accuracy is within +/-20%, and sizing accuracy is within +/-7% compared to controls.
• Intra-assay precision (RSD) is <10% for concentration and <2% for sizing, with acceptable inter-assay precision (<25% for quantitation, <2% for sizing).
• The limit of quantitation (LOQ) is 15.4 ng/µL and the limit of detection (LOD) is 5.4 ng/µL.
• The Bioanalyzer can distinguish RNA from DNA contamination and is affected by protein contamination and buffer ionic strength.

Conclusions:

• The Agilent 2100 Bioanalyzer provides a validated, precise, and accurate method for characterizing RNA transcripts.
• This automated system offers a reliable alternative to traditional RNA analysis techniques.
• The method's robustness and ability to detect contaminants highlight its utility in molecular biology research.